BEIZRAY
NDC 70710-2092, Docetaxel, injection, solution, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-2092
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218711
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2092 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCETAXEL ANHYDROUS20 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-2092-8 | 70710209208 | 1 VIAL, GLASS in 1 CARTON (70710-2092-8) / 1 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8fb7d980-d6c7-468b-a9f0-adff16101a4bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70710-2092
Use it
Look up 70710-2092 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-2092 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-2092. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.